Notification for amendment in Morpholine Quality Control Order2020 reg

## Report on the Morpholine Quality Control Amendment Order, 2021 **1. Executive Summary:** This report analyzes the Morpholine Quality Control Amendment Order, 2021, published by the Ministry of Chemicals and Fertilizers, Department of Chemicals and Petrochemicals. This amendment modifies the Morpholine Quality Control Order, 2020, specifically changing the date on which the original order comes into force. The key finding is the postponement of the effective date of the original order to February 1, 2022. **2. Introduction:** This report aims to provide a comprehensive overview of the Morpholine Quality Control Amendment Order, 2021 (S.O. 2030(E)), based solely on the information provided in the official gazette notification. The report focuses on the specific changes introduced by the amendment and their potential implications. **3. Policy Overview:** * **Original Policy Being Amended:** Morpholine Quality Control Order, 2020 (S.O. 1983(E) dated 16.06.2020). * **Core Objective(s):** While the text does not explicitly state the core objective of the original 2020 order, it can be inferred that the order aims to ensure the quality control of Morpholine, likely for public interest, as indicated by the reference to Section 16 of the Bureau of Indian Standards Act, 2016. **4. Background and Rationale:** The amendment specifically addresses the effective date of the original Morpholine Quality Control Order, 2020. The original order's immediate implementation timeframe, as originally stipulated, was evidently not feasible or practical, necessitating a postponement. The amendment likely aims to allow stakeholders more time to prepare for and comply with the quality control standards outlined in the original order. **5. Key Provisions / Changes:** This is an amendment. The core change introduced by the amendment is: * **Part of Original Policy Changed:** Paragraph 1, Subparagraph 2 of the Morpholine Quality Control Order, 2020. * **New Rule/Provision:** The original provision stipulating the order's commencement is replaced with the following: "It shall come into force on the 1st day of February, 2022." * **Effect of Change:** The change delays the effective date of the Morpholine Quality Control Order, 2020 from its original, unspecified commencement date to February 1, 2022. This grants affected parties a longer timeframe to meet the requirements stipulated in the original order. **6. Target Audience and Stakeholders:** Based on the text, the target audience and stakeholders directly affected by this amendment and the original order include: * Manufacturers and suppliers of Morpholine. * Businesses that use Morpholine in their production processes. * The Bureau of Indian Standards. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Ministry of Chemicals and Fertilizers, Department of Chemicals and Petrochemicals is the primary responsible agency. The Bureau of Indian Standards is also involved, as the Central Government consulted with them before issuing the amendment. * **Timelines:** The key timeline is the new effective date of the original order: February 1, 2022. * **Specific to Amendment:** The amendment itself requires no specific implementation steps beyond its publication in the Official Gazette. It is a change to the original order's timeline. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of this amendment is to provide stakeholders with sufficient time to prepare for and comply with the Morpholine Quality Control Order, 2020. This delay may: * Allow manufacturers to upgrade their production processes to meet the required quality standards. * Facilitate smoother adoption of the quality control measures. * Minimize disruptions to the supply chain of Morpholine. **9. Conclusion:** The Morpholine Quality Control Amendment Order, 2021 represents a postponement of the effective date of the original Morpholine Quality Control Order, 2020, to February 1, 2022. This change suggests that stakeholders required additional time to align with the quality control standards, ensuring a more effective and less disruptive implementation of the policy. This amendment is significant as it allows for a more practical and achievable transition to the new quality control regime for Morpholine, ultimately supporting the public interest.

Key Entities Referenced